Communications technology and services company Ericsson said Wednesday it has signed a “healthcare IoT strategic MoU” with China Mobile and biopharmaceutical company AstraZeneca to connect healthcare equipment using NB-IoT technology. The partnership aims to capitalize on the potential of Wuxi’s IoT for healthcare industry.
Under the MoU, the four parties will work together to develop and promote the IoT-based disease management solutions from diagnosis to treatment. They will also display the advanced smart healthcare solutions in therapy areas such as respiratory, cardiovascular, metabolic, gastrointestinal diseases, and oncology.
With Ericsson’s support, AstraZeneca will connect healthcare equipment and integrate end-to-end resources by introducing latest NB-IoT technology to bring end-to-end functional certification and integration.
Ericsson will collaborate with China Mobile Jiangsu branch to trial new applications using latest Cellular IoT technologies such as NB-IoT, and to provide network terminal management system to support real-time surveillance and equipment management. Ericsson will also support the government in the construction of a healthcare IoT base and innovation center in Wuxi and Jiangsu using Ericsson Device Connection Platform (DCP) and the connected global resources when the conditions are in place, the company said.
AstraZeneca will join hands with cross-sector partners in the first half of 2017 to establish the IoT Healthcare Alliance. The alliance will leverage the advantages of different parties including government bodies, enterprises, universities, research institutions, and hospitals to facilitate standardization of the IoT for healthcare industry as well as the commercialization of pilot projects, to speed up local incubation and talent cultivation, and to work together to build an innovative healthcare ecosystem, according to Ericsson.
“AstraZeneca is very excited to enter into a strategic partnership with WND, Jiangsu Mobile, and Ericsson,” said Leon Wang, AstraZeneca Executive Vice President, Asia Pacific Region and China President. “With the key value of ‘patient-centered’, this partnership will be committed to building IoT-based disease management solutions from diagnosis to treatment in therapy areas such as respiratory, cardiovascular, metabolic, gastrointestinal diseases, and oncology.”